Herbalife's third-quarter report provides a useful checkpoint on whether the company's multi-year turnaround is gaining sustained traction. After navigating uneven growth and restructuring efforts, the business has now delivered five straight quarters of year-over-year sales expansion. From what I see, investors are focused on whether this recovery is spreading across regions or still concentrated in key markets like India. The results also shed light on distributor trends, pricing dynamics, and cash generation, factors that influence how the market values the stock given its debt levels.
For the third quarter ended September 30, 2026, HLF reported net sales of $1,350.2 million, up 6.0% from $1,273.7 million a year earlier and above the consensus revenue estimate of roughly $1.32 billion. Adjusted diluted EPS was $0.64, beating the consensus estimate of $0.62. On a GAAP basis, diluted EPS was $0.55, up from $0.42 in the prior-year period.
Net income attributable to Herbalife was $58.8 million, up 36% year over year. Adjusted EBITDA rose to $182 million, above the company's guidance range of $160 million to $180 million, with adjusted EBITDA margin expanding 70 basis points to 13.5%. Gross profit margin was 77.3%, down 40 basis points year over year, reflecting country mix and sourcing costs partly offset by pricing benefits. Worldwide volume increased 8.6%. I also checked this using Tickeron's AI Screener to see how the stock compares to others in the industry.
Shares of HLF moved higher following the release, with investors responding positively to an earnings beat and revenue that exceeded consensus. The market's reaction appeared driven by the company's fifth consecutive quarter of growth, above-guidance adjusted EBITDA, and strengthening cash flow. India's outsized contribution was a focal point, with some attention on whether the country's growth is sustainable as the company laps a favorable comparison from the prior year. Foreign-exchange headwinds remained a factor but did not derail the broadly upbeat tone.
Looking ahead, investors will be watching whether Herbalife can sustain its growth streak as it laps a strong prior-year comparison in India. The company has signaled that it expects continued growth in that market even after lapping the change in India's GST that boosted prior-period results.
Margin trends will be another key focus. While adjusted EBITDA margin expanded year over year, gross margin declined modestly on country mix and self-manufacturing costs. The balance between pricing benefits and these cost pressures will help determine whether profitability gains continue.
Cash generation and debt reduction also remain central themes. With year-to-date operating cash flow up about 27%, investors will monitor leverage progress and any capital-allocation updates. Finally, strategic initiatives, including the expansion of the Bioniq premium wellness brand and broader distributor ecosystem investments, may provide additional catalysts in the quarters ahead.
When analyzing earnings-driven moves like this one from HLF, I often turn to Tickeron's AI-powered tools to scan for similar patterns across the sector. The AI Screener helps surface comparable setups and momentum signals that complement traditional fundamental review, giving a clearer view of potential trade opportunities without replacing core analysis.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
HLF moved above its 50-day moving average on October 01, 2026 date and that indicates a change from a downward trend to an upward trend. In 30 of 38 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 79%.
The Momentum Indicator moved above the 0 level on November 03, 2026. You may want to consider a long position or call options on HLF as a result. In 63 of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 74%.
The Moving Average Convergence Divergence (MACD) for HLF just turned positive on November 04, 2026. Looking at past instances where HLF's MACD turned positive, the stock continued to rise in 34 of 45 cases over the following month. The odds of a continued upward trend are 76%.
The 10-day moving average for HLF crossed bullishly above the 50-day moving average on October 01, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 64%.
Following a +15.29% 3-day Advance, the price is estimated to grow further. Considering data from situations where HLF advanced for three days, in 205 of 276 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.
The Aroon Indicator entered an Uptrend today. In 139 of 187 cases where HLF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 74%.
The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HLF declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
HLF broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron PE Growth Rating for this company is 2 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 6 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. HLF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 40 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-3.291) is normal, around the industry mean (6.787). P/E Ratio (9.430) is within average values for comparable stocks, (7.254). Projected Growth (PEG Ratio) (0.120) is also within normal values, averaging (8.458). Dividend Yield (0.040) settles around the average of (0.049) among similar stocks. P/S Ratio (0.241) is also within normal values, averaging (5.003).
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HLF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of weight management and personal care products
Industry FoodMajorDiversified